Top

Published in:

01-09-2018 | Letter to the Editor

Reappearance of hypomineralized bone after discontinuation of asfotase alfa treatment for severe childhood hypophosphatasia

Authors: S. A. Bowden, B. H. Adler

Excerpt

Dear Editor: …

Whyte MP (2016) Hypophosphatasia—aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol 12(4):233–246CrossRefPubMed

Whyte MP (2017) Hypophosphatasia: An overview for 2017. Bone

Bowden SA, Adler BH (2017) Asfotase alfa treatment for 1 year in a 16 year-old male with severe childhood hypophosphatasia. Osteoporos Int

STRENSIQ™ (asfotase alfa) [prescribing information]. Cheshire, CT: Alexion Pharmaceuticals, Inc; 2015. Available from: http://www.alexion.com/Documents/Strensiq_USPI.aspx

Millán JL (2013) The role of phosphatases in the initiation of skeletal mineralization. Calcif Tissue Int 93(4):299–306CrossRefPubMed

Title: Reappearance of hypomineralized bone after discontinuation of asfotase alfa treatment for severe childhood hypophosphatasia
Authors: S. A. Bowden
B. H. Adler
Publication date: 01-09-2018
Publisher: Springer London
Published in: Osteoporosis International / Issue 9/2018
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-018-4613-7